Predicting the outcome of peptide receptor radionuclide therapy in neuroendocrine tumors: the importance of dual-tracer imaging

Paolo Zanotti-Fregonara; Clément Morgat; Christophe Champion; Elif Hindié

doi:10.1007/s00259-017-3667-7

Predicting the outcome of peptide receptor radionuclide therapy in neuroendocrine tumors: the importance of dual-tracer imaging

Paolo Zanotti-Fregonara, Clément Morgat, Christophe Champion, Elif Hindié

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	1095-1096
Number of pages	2
Journal	European Journal of Nuclear Medicine and Molecular Imaging
Volume	44
Issue number	6
DOIs	https://doi.org/10.1007/s00259-017-3667-7
State	Published - Jun 1 2017

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging

Access to Document

10.1007/s00259-017-3667-7

Cite this

Predicting the outcome of peptide receptor radionuclide therapy in neuroendocrine tumors: the importance of dual-tracer imaging. / Zanotti-Fregonara, Paolo; Morgat, Clément; Champion, Christophe et al.
In: European Journal of Nuclear Medicine and Molecular Imaging, Vol. 44, No. 6, 01.06.2017, p. 1095-1096.

Research output: Contribution to journal › Letter › peer-review

@article{2ce577ba0df5464fbcd77bf561c03534,

title = "Predicting the outcome of peptide receptor radionuclide therapy in neuroendocrine tumors: the importance of dual-tracer imaging",

author = "Paolo Zanotti-Fregonara and Cl{\'e}ment Morgat and Christophe Champion and Elif Hindi{\'e}",

year = "2017",

month = jun,

day = "1",

doi = "10.1007/s00259-017-3667-7",

language = "English (US)",

volume = "44",

pages = "1095--1096",

journal = "European Journal of Nuclear Medicine and Molecular Imaging",

issn = "1619-7070",

publisher = "Springer Verlag",

number = "6",

}

TY - JOUR

T1 - Predicting the outcome of peptide receptor radionuclide therapy in neuroendocrine tumors

T2 - the importance of dual-tracer imaging

AU - Zanotti-Fregonara, Paolo

AU - Morgat, Clément

AU - Champion, Christophe

AU - Hindié, Elif

PY - 2017/6/1

Y1 - 2017/6/1

UR - http://www.scopus.com/inward/record.url?scp=85014786124&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85014786124&partnerID=8YFLogxK

U2 - 10.1007/s00259-017-3667-7

DO - 10.1007/s00259-017-3667-7

M3 - Letter

C2 - 28283701

AN - SCOPUS:85014786124

SN - 1619-7070

VL - 44

SP - 1095

EP - 1096

JO - European Journal of Nuclear Medicine and Molecular Imaging

JF - European Journal of Nuclear Medicine and Molecular Imaging

IS - 6

ER -

Predicting the outcome of peptide receptor radionuclide therapy in neuroendocrine tumors: the importance of dual-tracer imaging

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this